F18‑fluorodeoxyglucose positron emission tomography/computed tomography for bone hemangiopericytoma

  • Authors:
    • Yiyan Liu
  • View Affiliations

  • Published online on: October 18, 2017     https://doi.org/10.3892/mco.2017.1458
  • Pages:1147-1151
Metrics: PDF 0 views | HTML 0 views
0

Abstract

Bone hemangiopericytoma (HPC) is extremely rare, and its clinical manifestations and radiographic features are nonspecific. There are few case reports about application of F18‑fluorodeoxyglucose (FDG) positron emission tomography/computed tomography (PET/CT) in HPC. A total of four subjects with pathologically diagnosed bone HPC had FDG PET/CT for staging and/or restaging bone HPC. Medical records were retrospectively reviewed for radiological, pathological and follow‑up information. All primary bone and metastatic lesions demonstrated high FDG avidity on PET/CT, which also revealed the adjacent soft tissue involvement and synchronous lesion. PET/CT correctly detected metastatic lesions in 1 patient. Furthermore, 3/4 patients with available laboratory data had hypocalcemia, but normal phosphorus levels when HPC existed as primary lesions or metastatic disease; however, normalization of calcium levels when they were disease‑free. The results suggested that FDG PET/CT could be effectively used for staging, surveillance and detection of recurrent/metastatic disease in HPC. There may be an association between bone HPC and hypocalcemia.

Related Articles

Journal Cover

December 2017
Volume 7 Issue 6

Print ISSN: 2049-9450
Online ISSN:2049-9469

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
APA
Liu, Y. (2017). F18‑fluorodeoxyglucose positron emission tomography/computed tomography for bone hemangiopericytoma. Molecular and Clinical Oncology, 7, 1147-1151. https://doi.org/10.3892/mco.2017.1458
MLA
Liu, Y."F18‑fluorodeoxyglucose positron emission tomography/computed tomography for bone hemangiopericytoma". Molecular and Clinical Oncology 7.6 (2017): 1147-1151.
Chicago
Liu, Y."F18‑fluorodeoxyglucose positron emission tomography/computed tomography for bone hemangiopericytoma". Molecular and Clinical Oncology 7, no. 6 (2017): 1147-1151. https://doi.org/10.3892/mco.2017.1458